Workflow
Lost Money on Everus Construction Group, Inc. (ECG)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
GlobeNewswire News Room· 2025-05-16 17:15
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Everus Construction Group, Inc. ("Everus Construction " or the "Company") (NYSE: ECG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Everus Construction investors who were adversely affected by alleged securities fraud between October 31, 2024 and February 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk. ...
Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
GlobeNewswire News Room· 2025-05-16 17:14
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025. Follow the link below to get more information and be contacted by a ...
June 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CAR
GlobeNewswire News Room· 2025-05-16 17:13
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avis Budget Group, Inc. ("Avis Budget" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avis Budget investors who were adversely affected by alleged securities fraud between February 16, 2024 and February 10, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/avis-budge ...
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 – SANA
GlobeNewswire News Room· 2025-05-16 17:12
Core Viewpoint - A class action securities lawsuit has been filed against Sana Biotechnology, Inc. due to alleged securities fraud affecting investors between March 17, 2023, and November 4, 2024 [1][2]. Group 1: Allegations and Financial Concerns - The lawsuit claims that Sana was at significant risk of having insufficient funds to maintain its operations and advance its product candidates [2]. - It is alleged that the product candidates SC291 in oncology, SC379, and SG299 were less promising than previously communicated to investors [2]. - To preserve cash and focus on more promising candidates, Sana was likely to decrease funding for or discontinue SC291, SC379, and SG299, as well as significantly reduce its workforce [2]. - The defendants are accused of overstating Sana's financial capacity to maintain operations and advance existing product candidates, leading to materially false and misleading public statements [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the relevant timeframe have until May 20, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].
Lost Money on Napco Security Technologies, Inc. (NSSC)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
GlobeNewswire News Room· 2025-05-16 17:12
Core Viewpoint - Napco Security Technologies, Inc. is facing a class action lawsuit due to alleged securities fraud that impacted investors between February 5, 2024, and February 3, 2025 [1] Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors affected by misleading statements regarding Napco's growth and hardware division performance [2] - Defendants expressed confidence in achieving fiscal 2026 growth projections based on demand for hardware products, which was later contradicted by a significant decline in hardware sales reported on February 3, 2025 [2] - Following the announcement of reduced sales and a retraction of the long-term 45% EBITDA margin target, Napco's stock price plummeted from $36.70 on January 31, 2024, to $26.93 on February 3, 2025, marking a decline of approximately 26.62% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 24, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without incurring out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as a leading securities litigation firm in the United States [4]
IBTA LAWSUIT ALERT: Levi & Korsinsky Notifies Ibotta, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
GlobeNewswire News Room· 2025-05-16 17:12
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ibotta, Inc. ("Ibotta" or the "Company") (NYSE: IBTA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ibotta investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded Ibotta securities pursuant and/or traceable to documents issued in connection with Ibotta’s ...
AmEx is Holding Strong: But is That Enough for Investors Right Now?
ZACKS· 2025-05-16 17:11
American Express Company (AXP) continues to showcase the strength of its premium brand in a volatile macroeconomic environment. Backed by a high-spending, affluent customer base and consistent earnings performance, the company has held up better than many of its peers. As one of Berkshire Hathaway’s longest-standing holdings, AmEx is often regarded as a quality name. However, it’s not immune to global headwinds. From tariff-related uncertainties to evolving credit risk dynamics and shifting consumer behavio ...
Will Sound Point Meridian Capital, Inc. (SPMC) Beat Estimates Again in Its Next Earnings Report?
ZACKS· 2025-05-16 17:11
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Sound Point Meridian Capital, Inc. (SPMC) , which belongs to the Zacks Financial - Investment Management industry, could be a great candidate to consider.This company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 26.94%.Fo ...
Investors who lost money on Actinium Pharmaceuticals, Inc.(ATNM) should contact Levi & Korsinsky about pending Class Action - ATNM
GlobeNewswire News Room· 2025-05-16 17:11
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Actinium investors who were adversely affected by alleged securities fraud between October 31, 2022 and August 2, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/actinium-lawsu ...
Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference
Prnewswire· 2025-05-16 17:11
SECAUCUS, N.J., May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a presentation at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 11:00 a.m. Eastern Time.The presentation session will be webcast live during the conference on the company's ...